Avalyn Pharma Inc. (AVLN)
Nasdaq: AVLN · Pharmaceutical Preparations · filing with the SEC since 2012
Who owns Avalyn Pharma Inc.
As filed with the SECHolders of 5% or more
6
Fmr LLC holds 13.2% of Common Shares, as its SCHEDULE 13G/A filed Aug 6, 2026 says.
Directors and officers
12
report now, of 12 people on the record since 2026. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 6 named at left.
Holders of 5% or moreshare of the class, as filed
Fmr LLC
SCHEDULE 13G/A · filed Aug 6, 2026 · Common Shares · 11.5% in May 5, 2026
Novo Holdings A/S
SCHEDULE 13G · filed Aug 14, 2026 · Voting Common Stock, par value $0.001 per share
SR One Capital Management, LLC
SCHEDULE 13D · filed May 8, 2026 · Common Stock, par value $0.001 per share
Perceptive Advisors LLC
SCHEDULE 13G · filed May 7, 2026 · Common Stock, $0.001 par value
Suvretta Capital Management, LLC
SCHEDULE 13D · filed May 8, 2026 · Voting Common Stock, $0.001 par value
Norwest Venture Partners XV, LP
SCHEDULE 13G · filed Aug 11, 2026 · Voting Common Stock, $0.001 par value per share
What AVLN reports owning in othersstakes of 5% or more, and other ties
Avalyn Pharma Inc. reports no stake in another company in the record.
Insider tradesForm 4
0sales
1purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$5.0Mbought, in dollars
Open-market trades on Form 4 from Nov 12, 2025 to Nov 12, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 12, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window4 of 17 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Fmr LLC | 10% owner | 4 | $6.7M | 0 | 0 | $0 |
| George Simeon | 10% owner | 0 | $0 | 0 | 2 | $10.0M |
| Carroll Jill | director | 0 | $0 | 0 | 1 | $5.0M |
| Novo Holdings A/s | 10% owner | 0 | $0 | 0 | 1 | $10.0M |